El Jurdi, Najla http://orcid.org/0000-0002-9268-9655
Elhusseini, Heba
Beckman, Joan
DeFor, Todd E.
Okoev, Grigori http://orcid.org/0000-0003-3439-4362
Rogosheske, John
Lazaryan, Aleksandr http://orcid.org/0000-0001-9605-6436
Weiler, Kristen
Bachanova, Veronika http://orcid.org/0000-0002-9325-432X
Betts, Brian C.
Blazar, Bruce R.
Brunstein, Claudio G. http://orcid.org/0000-0002-1997-3799
He, Fiona http://orcid.org/0000-0003-0782-1170
Holtan, Shernan G.
Janakiram, Murali http://orcid.org/0000-0001-9323-8007
Gangaraju, Radhika
Maakaron, Joseph http://orcid.org/0000-0002-1732-6694
MacMillan, Margaret L. http://orcid.org/0000-0002-0755-0852
Rashidi, Armin
Warlick, Erica D.
Bhatia, Smita
Vercellotti, Gregory
Weisdorf, Daniel J. http://orcid.org/0000-0001-8078-8579
Arora, Mukta
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | Center for Scientific Review (P30 CA77598)
U.S. Department of Health & Human Services | NIH | National Center for Advancing Translational Sciences (UL1TR002494)
Article History
Received: 15 March 2021
Revised: 20 April 2021
Accepted: 29 April 2021
First Online: 18 May 2021
Conflict of interest
: D.J.W.—research support from Incyte. B.R.B.—founder of Tmunity Therapeutics, advisory board member for Kadmon Pharmaceuticals, Magenta Therapeutics, and BlueRock Therapeutics and receives research funding from BlueRock Therapeutics. S.G.H.—consultant for Incyte. The remaining authors declare no competing interests.